Novavax to present vaccine progress tomorrow morning

The company R&D chief, Gregory Glenn, will present progress of Covid-19 vaccine candidate NVX-CoV2373 at 9:55 AM tomorrow at the 2nd International Society for Vaccines Virtual Congress.

The free webinar is here.

Novavax (NASDAQ:NVAX) fell 1.6% in the regular session today, but is up 8.6% after hours on this news.

https://seekingalpha.com/news/3592816-novavax-to-present-vaccine-progress-tomorrow-morning-shares-rise-after-hours